$AXON
AXON ENTERPRISE, INC.

2023 Q4 Form 10-Q Financial Statement

#000155837023018023 Filed on November 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $432.1M $413.6M
YoY Change 28.56% 32.67%
Cost Of Revenue $168.3M $158.3M
YoY Change 28.97% 33.61%
Gross Profit $263.9M $255.3M
YoY Change 28.3% 32.09%
Gross Profit Margin 61.06% 61.72%
Selling, General & Admin $137.1M $123.3M
YoY Change 19.83% 20.83%
% of Gross Profit 51.96% 48.29%
Research & Development $83.97M $76.88M
YoY Change 22.19% 30.03%
% of Gross Profit 31.82% 30.12%
Depreciation & Amortization $10.05M $8.400M
YoY Change 61.85% 35.35%
% of Gross Profit 3.81% 3.29%
Operating Expenses $221.1M $200.2M
YoY Change 20.72% 24.21%
Operating Profit $42.81M $55.11M
YoY Change 89.92% 71.65%
Interest Expense $54.89M $14.31M
YoY Change 350.36% -227.21%
% of Operating Profit 128.23% 25.96%
Other Income/Expense, Net -$41.90M $3.852M
YoY Change
Pretax Income $55.80M $69.42M
YoY Change 60.67% 232.84%
Income Tax -$1.469M $10.03M
% Of Pretax Income -2.63% 14.44%
Net Earnings $57.27M $59.40M
YoY Change 96.3% 389.63%
Net Earnings / Revenue 13.25% 14.36%
Basic Earnings Per Share $0.79
Diluted Earnings Per Share $0.75 $0.78
COMMON SHARES
Basic Shares Outstanding 74.93M 74.76M
Diluted Shares Outstanding 75.95M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $676.5M $474.9M
YoY Change 72.17% 159.52%
Cash & Equivalents $598.5M $406.0M
Short-Term Investments $77.94M $68.85M
Other Short-Term Assets $112.8M $103.8M
YoY Change 54.45% 52.53%
Inventory $269.9M $260.1M
Prepaid Expenses
Receivables $693.5M $703.4M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.397B $2.258B
YoY Change 32.76% 87.26%
LONG-TERM ASSETS
Property, Plant & Equipment $200.5M $187.0M
YoY Change 18.07% 13.89%
Goodwill $57.95M $57.34M
YoY Change 28.82% 27.95%
Intangibles $19.54M $20.32M
YoY Change 60.71% 55.87%
Long-Term Investments $231.7M $240.3M
YoY Change -48.82% -24.64%
Other Assets $220.6M $194.5M
YoY Change 38.23% 75.83%
Total Long-Term Assets $1.040B $996.3M
YoY Change -0.61% 23.81%
TOTAL ASSETS
Total Short-Term Assets $2.397B $2.258B
Total Long-Term Assets $1.040B $996.3M
Total Assets $3.437B $3.254B
YoY Change 20.51% 61.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $88.33M $90.04M
YoY Change 47.41% 79.38%
Accrued Expenses $188.2M $146.9M
YoY Change 20.71% 30.31%
Deferred Revenue $491.7M $454.9M
YoY Change 36.57% 84.58%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $800.0M $717.8M
YoY Change 32.74% 66.35%
LONG-TERM LIABILITIES
Long-Term Debt $677.1M $676.3M
YoY Change 0.47%
Other Long-Term Liabilities $2.936M $2.960M
YoY Change -36.35% -37.98%
Total Long-Term Liabilities $2.936M $2.960M
YoY Change -36.35% -37.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $800.0M $717.8M
Total Long-Term Liabilities $2.936M $2.960M
Total Liabilities $1.825B $1.733B
YoY Change 15.25% 122.44%
SHAREHOLDERS EQUITY
Retained Earnings $431.2M $374.0M
YoY Change 67.79% 64.14%
Common Stock $1.347B $1.316B
YoY Change 14.71% 12.74%
Preferred Stock
YoY Change
Treasury Stock (at cost) $155.9M $155.9M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $1.612B $1.521B
YoY Change
Total Liabilities & Shareholders Equity $3.437B $3.254B
YoY Change 20.51% 61.87%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $57.27M $59.40M
YoY Change 96.3% 389.63%
Depreciation, Depletion And Amortization $10.05M $8.400M
YoY Change 61.85% 35.35%
Cash From Operating Activities $140.0M $62.90M
YoY Change 6.8% 53.79%
INVESTING ACTIVITIES
Capital Expenditures $24.07M $14.40M
YoY Change 105.74% -199.59%
Acquisitions
YoY Change
Other Investing Activities $77.24M -$107.6M
YoY Change -114.93% 21.23%
Cash From Investing Activities $53.17M -$122.0M
YoY Change -110.05% 18.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.818M -7.200M
YoY Change -100.64% 9900.0%
NET CHANGE
Cash From Operating Activities 140.0M 62.90M
Cash From Investing Activities 53.17M -122.0M
Cash From Financing Activities -3.818M -7.200M
Net Change In Cash 189.4M -66.30M
YoY Change -6.57% 6.27%
FREE CASH FLOW
Cash From Operating Activities $140.0M $62.90M
Capital Expenditures $24.07M $14.40M
Free Cash Flow $116.0M $48.50M
YoY Change -2.89% -12.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001069183
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71474581
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74931697
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-16391
dei Entity Registrant Name
EntityRegistrantName
Axon Enterprise, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0741227
dei Entity Address Address Line1
EntityAddressAddressLine1
17800 North 85th Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85255
dei City Area Code
CityAreaCode
480
dei Local Phone Number
LocalPhoneNumber
991-0797
dei Security12b Title
Security12bTitle
Common Stock, $0.00001 Par Value
dei Trading Symbol
TradingSymbol
AXON
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
74933831
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
406042000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
353684000
CY2023Q3 us-gaap Marketable Securities
MarketableSecurities
68850000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
39240000
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
715688000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
581769000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2144000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2176000
CY2023Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
442830000
CY2022Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
358190000
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
260523000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
196902000
CY2023Q3 us-gaap Inventory Net
InventoryNet
260119000
CY2022Q4 us-gaap Inventory Net
InventoryNet
202471000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
103789000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
73022000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2257841000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1805278000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
186957000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
169843000
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
213831000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
156866000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20324000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12158000
CY2023Q3 us-gaap Goodwill
Goodwill
57344000
CY2022Q4 us-gaap Goodwill
Goodwill
44983000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
156207000
CY2023Q3 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
4381000
CY2022Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
5210000
CY2023Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
78663000
CY2022Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
45170000
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
240299000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
296563000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
194543000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
159616000
CY2023Q3 us-gaap Assets
Assets
3254183000
CY2022Q4 us-gaap Assets
Assets
2851894000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
90035000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
59918000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
146940000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
155934000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
454891000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
360037000
CY2023Q3 axon Customer Deposit Current
CustomerDepositCurrent
16469000
CY2022Q4 axon Customer Deposit Current
CustomerDepositCurrent
20399000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9492000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6358000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
717827000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
602646000
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
270082000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
248003000
CY2023Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
18938000
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
10745000
CY2023Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
9148000
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
6285000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2467000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
35329000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37143000
CY2023Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
676315000
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
673967000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2960000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4613000
CY2023Q3 us-gaap Liabilities
Liabilities
1733066000
CY2022Q4 us-gaap Liabilities
Liabilities
1583403000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74931697
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71474581
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
1000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1315954000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1174594000
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
20220227
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
20220227
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
155947000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
155947000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
373978000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
257022000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12869000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7179000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1521117000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1268491000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3254183000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2851894000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
413601000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
311754000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1131249000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
853793000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
158329000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
118497000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
439754000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
330834000
CY2023Q3 us-gaap Gross Profit
GrossProfit
255272000
CY2022Q3 us-gaap Gross Profit
GrossProfit
193257000
us-gaap Gross Profit
GrossProfit
691495000
us-gaap Gross Profit
GrossProfit
522959000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
123279000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
102023000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
359768000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
287157000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
76880000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
59127000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
219747000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
165090000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
200159000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
161150000
us-gaap Operating Expenses
OperatingExpenses
579515000
us-gaap Operating Expenses
OperatingExpenses
452247000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
55113000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
32107000
us-gaap Operating Income Loss
OperatingIncomeLoss
111980000
us-gaap Operating Income Loss
OperatingIncomeLoss
70712000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
14310000
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-11249000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-12782000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
91076000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
69423000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20858000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
99198000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
161788000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10026000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8727000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-17758000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43824000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
59397000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
12131000
us-gaap Net Income Loss
NetIncomeLoss
116956000
us-gaap Net Income Loss
NetIncomeLoss
117964000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.66
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.63
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74826000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71107000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73904000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71033000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75952000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72525000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75212000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72386000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
59397000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
12131000
us-gaap Net Income Loss
NetIncomeLoss
116956000
us-gaap Net Income Loss
NetIncomeLoss
117964000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6799000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2275000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5680000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5513000
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
656000
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-326000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-10000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-976000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
53254000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9530000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
111266000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
111475000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1268491000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
33650000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-34841000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
54346000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34350000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
45139000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1860000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1402995000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
61156000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-62214000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
157000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31891000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
12420000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1407000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1444998000
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-101000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-7021000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29987000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
59397000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6143000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1521117000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1047849000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-70000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-1388000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25088000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
54871000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1561000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1124789000
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-4000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-931000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21162000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
50962000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2327000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1193651000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-72000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28204000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
12131000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2601000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1231313000
us-gaap Profit Loss
ProfitLoss
116956000
us-gaap Profit Loss
ProfitLoss
117964000
us-gaap Share Based Compensation
ShareBasedCompensation
96228000
us-gaap Share Based Compensation
ShareBasedCompensation
74454000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-53311000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
30349000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-42306000
us-gaap Gain Loss On Investments
GainLossOnInvestments
92498000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22587000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18171000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-12071000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-61000
axon Non Cash Lease Expense
NonCashLeaseExpense
4890000
axon Non Cash Lease Expense
NonCashLeaseExpense
4997000
axon Provision For Unrecognized Tax Benefits
ProvisionForUnrecognizedTaxBenefits
4302000
axon Provision For Unrecognized Tax Benefits
ProvisionForUnrecognizedTaxBenefits
3519000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2328000
axon Payment Of Coupon Interest
PaymentOfCouponInterest
1073000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1140000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2659000
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
182468000
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
115046000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
59564000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
66267000
axon Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
64608000
axon Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
17871000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13423000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
28684000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
118294000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
115187000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
49225000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
104241000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
426993000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
194142000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
461214000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15485000
axon Payments On Exercise Of Warrants Of Strategic Investment
PaymentsOnExerciseOfWarrantsOfStrategicInvestment
6555000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
35624000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
44218000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
67000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
226000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
579000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
193000
axon Payments To Acquire Equity Securities Without Readily Determinable Fair Value
PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
17692000
axon Payments To Acquire Equity Securities Without Readily Determinable Fair Value
PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
70500000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
21090000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2104000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40697000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-302001000
axon Net Proceeds From Equity Offering
NetProceedsFromEquityOffering
94705000
axon Net Proceeds From Equity Offering
NetProceedsFromEquityOffering
-74000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
54503000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
104076000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2391000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45132000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2465000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1201000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-6783000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
52459000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-207008000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355552000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
356438000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
408011000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
149430000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
406042000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
147711000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1969000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1719000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
408011000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
149430000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
47689000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7503000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1784000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1244000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
59397000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
12131000
us-gaap Net Income Loss
NetIncomeLoss
116956000
us-gaap Net Income Loss
NetIncomeLoss
117964000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74826000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71107000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73904000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71033000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1126000
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1418000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1308000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1353000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75952000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72525000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75212000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72386000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.66
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.63
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6515000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2977000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6504000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2952000
axon Warranty Period After Purchase Of Product
WarrantyPeriodAfterPurchaseOfProduct
P1Y
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
811000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2822000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
901000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1988000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
3381000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
161000
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3291000
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
995000
CY2023Q3 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
5900000
CY2022Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
4300000
axon Investments In Number Of Affiliates
InvestmentsInNumberOfAffiliates
8
CY2023Q3 axon Debt Instrument Principal Amount Denomination For Fair Value Calculation
DebtInstrumentPrincipalAmountDenominationForFairValueCalculation
1000
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
2000000.0
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
1900000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassification of Prior Year Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications are not material and had no effect on the reported results of operations.</p>
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
413601000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
311754000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1131249000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
853793000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
413601000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
311754000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1131249000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
853793000
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
339186000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
724973000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
279223000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
454891000
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
270082000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
724973000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
360037000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
248003000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
608040000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
454891000
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
270082000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
724973000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
360037000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
248003000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
608040000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5800000000
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1213302000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
45000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
22767000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1190580000
CY2023Q3 axon Cash Cash Equivalent And Investments Amortized Cost
CashCashEquivalentAndInvestmentsAmortizedCost
406042000
CY2023Q3 us-gaap Marketable Securities
MarketableSecurities
68850000
CY2023Q3 axon Short Term Investment
ShortTermInvestment
715688000
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
390400000
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
390400000
CY2023Q3 axon Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Unrealized Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerUnrealizedLosses
27000000.0
CY2023Q3 axon Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Gross Unrealized Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerGrossUnrealizedLosses
300000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1183222000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
57000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
52379000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1130900000
CY2022Q4 axon Cash Cash Equivalent And Investments Amortized Cost
CashCashEquivalentAndInvestmentsAmortizedCost
353684000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
39240000
CY2022Q4 axon Short Term Investment
ShortTermInvestment
581769000
CY2022Q4 axon Long Term Investment
LongTermInvestment
156207000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3630000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
879000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
824000
axon Allowance For Doubtful Accounts Receivable Other
AllowanceForDoubtfulAccountsReceivableOther
-8000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3693000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2144000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2176000
CY2023Q3 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
1476000
CY2022Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
1360000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
59000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
94000
CY2023Q3 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
14000
CY2023Q3 axon Allowance For Expected Credit Losses On Customer Receivables
AllowanceForExpectedCreditLossesOnCustomerReceivables
3693000
CY2022Q4 axon Allowance For Expected Credit Losses On Customer Receivables
AllowanceForExpectedCreditLossesOnCustomerReceivables
3630000
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
104372000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
72740000
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
155747000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
129731000
CY2023Q3 us-gaap Inventory Net
InventoryNet
260119000
CY2022Q4 us-gaap Inventory Net
InventoryNet
202471000
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
233637000
CY2022Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
281691000
CY2023Q3 axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
5275000
CY2022Q3 axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
9356000
CY2023Q3 axon Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment And Impairment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAndImpairmentAnnualAmount
113000
CY2022Q3 axon Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment And Impairment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAndImpairmentAnnualAmount
718000
CY2023Q3 axon Equity Securities Without Readily Determinable Fair Value Exercises
EquitySecuritiesWithoutReadilyDeterminableFairValueExercises
1500000
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
240299000
CY2022Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
290329000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
296563000
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
83520000
axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
16192000
axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
70856000
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
0
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
70432000
axon Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment And Impairment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAndImpairmentAnnualAmount
73956000
axon Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment And Impairment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAndImpairmentAnnualAmount
1109000
axon Equity Securities Without Readily Determinable Fair Value Exercises
EquitySecuritiesWithoutReadilyDeterminableFairValueExercises
1500000
axon Equity Securities Without Readily Determinable Fair Value Exercises
EquitySecuritiesWithoutReadilyDeterminableFairValueExercises
66630000
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
240299000
CY2022Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
290329000
axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
145953000
axon Equity Securities Without Readily Determinable Fair Value Gain On Sale Of Securities
EquitySecuritiesWithoutReadilyDeterminableFairValueGainOnSaleOfSecurities
12312000
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
103890000
axon Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment And Impairment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAndImpairmentAnnualAmount
75440000
axon Equity Securities Without Readily Determinable Fair Value Exercises
EquitySecuritiesWithoutReadilyDeterminableFairValueExercises
68130000
axon Equity Securities Without Readily Determinable Fair Value Sales
EquitySecuritiesWithoutReadilyDeterminableFairValueSales
14546000
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
240299000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
92437000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
97882000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6102000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3861000
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3291000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
811000
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
3358000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
13559000
CY2023Q3 axon Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
11847000
CY2022Q4 axon Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
10548000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29905000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29273000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
146940000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
155934000
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
211400000
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
25600000
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
25600000
us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
5500000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.179
us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0.174
axon Effective Income Tax Rate Reconciliation Deduction Stockbased Compensation
EffectiveIncomeTaxRateReconciliationDeductionStockbasedCompensation
36800000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
246000000.0
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
29987000
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
28204000
us-gaap Share Based Compensation
ShareBasedCompensation
96228000
us-gaap Share Based Compensation
ShareBasedCompensation
74454000
axon Debt Instrument Covenant Consolidated Leverage Ratio
DebtInstrumentCovenantConsolidatedLeverageRatio
0.27
CY2023Q3 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
4
axon Product Claims Self Insurance
ProductClaimsSelfInsurance
5000000.0
CY2023Q4 axon Dispute Period
DisputePeriod
P5Y
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
413601000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
311754000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
158329000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
118497000
CY2023Q3 us-gaap Gross Profit
GrossProfit
255272000
CY2022Q3 us-gaap Gross Profit
GrossProfit
193257000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
76880000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
59127000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1131249000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
853793000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
439754000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
330834000
us-gaap Gross Profit
GrossProfit
691495000
us-gaap Gross Profit
GrossProfit
522959000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
219747000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
165090000
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true

Files In Submission

Name View Source Status
axon-20230930_cal.xml Edgar Link unprocessable
axon-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001558370-23-018023-index-headers.html Edgar Link pending
0001558370-23-018023-index.html Edgar Link pending
0001558370-23-018023.txt Edgar Link pending
0001558370-23-018023-xbrl.zip Edgar Link pending
axon-20230930.xsd Edgar Link pending
axon-20230930x10q.htm Edgar Link pending
axon-20230930xex31d1.htm Edgar Link pending
axon-20230930xex31d2.htm Edgar Link pending
axon-20230930xex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
axon-20230930_def.xml Edgar Link unprocessable
axon-20230930x10q_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
axon-20230930_pre.xml Edgar Link unprocessable